1.877.CALYPTE Based in Portland, Oregon, Calypte takes its name from Calypte anna, a hummingbird with brilliant emerald and ruby feathers that makes its home on the West Coast of North America. Calypte Biomedical Corporation Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus ( HIV ) infection, sexually transmitted diseases and other chronic diseases. Our innovative product line includes both point-of-case rapid tests and traditional ELISA/EIA diagnostic tests. Calypte also offers a broad range of recombinant proteins and antigens as well as proprietary reagents, buffers, and other specialty products to researchers seeking to develop and optimize immunodiagnostic assays. These unique products are based on technologies developed by Calypte scientists and are used throughout our range of in vitro diagnostic tests. Founded in 1988, Calypte is a pioneer in non-blood-based HIV antibody testing. We're the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot. * Today, our Aware' family of rapid oral fluid, blood and urine HIV tests offers unrivalled HIV 1/2 testing flexibility in a non-laboratory setting.